With 47 new drug approvals from the FDA so far in 2026, pharmacists and pharmacy technicians must stay informed about emerging treatment options and their potential impact on patient care. This continuing education activity will highlight selected newly approved medications, covering their mechanisms of action, clinical effectiveness, safety considerations and proper handling. Participants will gain valuable knowledge to help them remain current on new therapies and better support patients across a variety of disease states.

This knowledge-based continuing pharmacy education (CPE) activity focusing on New Drug Update is approved for 3 live contact hours (0.3 CEUs).

ACTIVITY ANNOUNCEMENT

Register - Pharmacists

Register - Pharmacy Technicians